Joseph Gonzalez-Heydrich, MD

Joseph Gonzalez-Heydrich, MD

Associate in Psychiatry

Assistant Professor, Harvard Medical School

  • Contact: 617-355-6680

  • Fax: 617-730-0319

Medical Services

Specialties

  • Psychopharmacology

Departments

  • Psychiatry

Languages

  • Spanish

Programs

  • Psychopharmacology Program
  • Psychosocial Treatment Program
To schedule an appointment: Call 617-355-6680 or Request an Appointment

Experience and Education

Education

Medical School

Johns Hopkins University School of Medicine, 1986

Baltimore, MD

Internship

Univ. of California Medical Center, 06/86 to 06/87

Los Angeles, CA

Residency

Stanford University, 07/89 to 06/90

Stanford, CA

Residency

Boston Children's Hospital, 07/93 to 06/95

Boston, MA

Certifications

  • Psychiatry, Child and Adolescent Psychiatry, Forensic Psychiatry

Publications

Publications powered by Harvard Catalyst Profiles
  1. Smedemark-Margulies N, Brownstein CA, Vargas S, Tembulkar SK, Towne MC, Shi J, Gonzalez-Cuevas E, Liu KX, Bilguvar K, Kleiman RJ, Han MJ, Torres A, Berry GT, Yu TW, Beggs AH, Agrawal PB, Gonzalez-Heydrich J. A novel de novo mutation in ATP1A3 and childhood-onset schizophrenia. Cold Spring Harb Mol Case Stud. 2016 Sep; 2(5):a001008.
  2. Brownstein CA, Kleiman RJ, Engle EC, Towne MC, D'Angelo EJ, Yu TW, Beggs AH, Picker J, Fogler JM, Carroll D, Schmitt RC, Wolff RR, Shen Y, Lip V, Bilguvar K, Kim A, Tembulkar S, O'Donnell K, Gonzalez-Heydrich J. Overlapping 16p13.11 deletion and gain of copies variations associated with childhood onset psychosis include genes with mechanistic implications for autism associated pathways: Two case reports. Am J Med Genet A. 2016 May; 170A(5):1165-73.
  3. Gonzalez-Heydrich J, Enlow MB, D'Angelo E, Seidman LJ, Gumlak S, Kim A, Woodberry KA, Rober A, Tembulkar S, O'Donnell K, Hamoda HM, Kimball K, Rotenberg A, Oberman LM, Pascual-Leone A, Keshavan MS, Duffy FH. N100 Repetition Suppression Indexes Neuroplastic Defects in Clinical High Risk and Psychotic Youth. Neural Plast. 2016; 2016:4209831.
  4. Gonzalez-Heydrich J, Bosquet Enlow M, D'Angelo E, Seidman LJ, Gumlak S, Kim A, Woodberry KA, Rober A, Tembulkar S, Graber K, O'Donnell K, Hamoda HM, Kimball K, Rotenberg A, Oberman LM, Pascual-Leone A, Keshavan MS, Duffy FH. Early auditory processing evoked potentials (N100) show a continuum of blunting from clinical high risk to psychosis in a pediatric sample. Schizophr Res. 2015 Dec; 169(1-3):340-5.
  5. Duffy FH, D'Angelo E, Rotenberg A, Gonzalez-Heydrich J. Neurophysiological differences between patients clinically at high risk for schizophrenia and neurotypical controls--first steps in development of a biomarker. BMC Med. 2015; 13:276.
  6. Szigethy E, Youk AO, Gonzalez-Heydrich J, Bujoreanu SI, Weisz J, Fairclough D, Ducharme P, Jones N, Lotrich F, Keljo D, Srinath A, Bousvaros A, Kupfer D, DeMaso DR. Effect of 2 psychotherapies on depression and disease activity in pediatric Crohn's disease. Inflamm Bowel Dis. 2015 Jun; 21(6):1321-8.
  7. Gonzalez-Heydrich J. Epilepsy & behavior: My intellectual home for 15 years! Epilepsy Behav. 2014 Nov; 40:96.
  8. Gonzalez-Heydrich J, Hsin O, Gumlak S, Kimball K, Rober A, Azeem MW, Hickory M, Mrakotsky C, Torres A, Mezzacappa E, Bourgeois B, Biederman J. Comparing stimulant effects in youth with ADHD symptoms and epilepsy. Epilepsy Behav. 2014 Jul; 36:102-7.
  9. Szigethy E, Bujoreanu SI, Youk AO, Weisz J, Benhayon D, Fairclough D, Ducharme P, Gonzalez-Heydrich J, Keljo D, Srinath A, Bousvaros A, Kirshner M, Newara M, Kupfer D, DeMaso DR. Randomized efficacy trial of two psychotherapies for depression in youth with inflammatory bowel disease. J Am Acad Child Adolesc Psychiatry. 2014 Jul; 53(7):726-35.
  10. Kahn J, Ducharme P, Rotenberg A, Gonzalez-Heydrich J. "RAGE-Control": A Game to Build Emotional Strength. Games Health J. 2013 Feb; 2(1):53-7.
  11. Show all
  12. Garcia G, Logan GE, Gonzalez-Heydrich J. Management of psychotropic medication side effects in children and adolescents. Child Adolesc Psychiatr Clin N Am. 2012 Oct; 21(4):713-38.
  13. Berry-Kravis EM, Hessl D, Rathmell B, Zarevics P, Cherubini M, Walton-Bowen K, Mu Y, Nguyen DV, Gonzalez-Heydrich J, Wang PP, Carpenter RL, Bear MF, Hagerman RJ. Effects of STX209 (arbaclofen) on neurobehavioral function in children and adults with fragile X syndrome: a randomized, controlled, phase 2 trial. Sci Transl Med. 2012 Sep 19; 4(152):152ra127.
  14. Thompson RD, Craig A, Crawford EA, Fairclough D, Gonzalez-Heydrich J, Bousvaros A, Noll RB, DeMaso DR, Szigethy E. Longitudinal results of cognitive behavioral treatment for youths with inflammatory bowel disease and depressive symptoms. J Clin Psychol Med Settings. 2012 Sep; 19(3):329-37.
  15. Munshi KR, Gonzalez-Heydrich J, Augenstein T, D'Angelo EJ. Evidence-based treatment approach to autism spectrum disorders. Pediatr Ann. 2011 Nov; 40(11):569-74.
  16. Torres A, Whitney J, Rao S, Tilley C, Lobel R, Gonzalez-Heydrich J. Tolerability of atomoxetine for treatment of pediatric attention-deficit/hyperactivity disorder in the context of epilepsy. Epilepsy Behav. 2011 Jan; 20(1):95-102.
  17. Oberman L, Ifert-Miller F, Najib U, Bashir S, Woollacott I, Gonzalez-Heydrich J, Picker J, Rotenberg A, Pascual-Leone A. Transcranial magnetic stimulation provides means to assess cortical plasticity and excitability in humans with fragile x syndrome and autism spectrum disorder. Front Synaptic Neurosci. 2010; 2:26.
  18. Gonzalez-Heydrich J, Whitney J, Waber D, Forbes P, Hsin O, Faraone SV, Dodds A, Rao S, Mrakotsky C, Macmillan C, Demaso DR, de Moor C, Torres A, Bourgeois B, Biederman J. Adaptive phase I study of OROS methylphenidate treatment of attention deficit hyperactivity disorder with epilepsy. Epilepsy Behav. 2010 Jul; 18(3):229-37.
  19. Bers MU, Beals LM, Chau C, Satoh K, Blume ED, DeMaso DR, Gonzalez-Heydrich J. Use of a virtual community as a psychosocial support system in pediatric transplantation. Pediatr Transplant. 2010 Mar; 14(2):261-7.
  20. Hamoda HM, Guild DJ, Gumlak S, Travers BH, Gonzalez-Heydrich J. Association between attention-deficit/hyperactivity disorder and epilepsy in pediatric populations. Expert Rev Neurother. 2009 Dec; 9(12):1747-54.
  21. Kahn J, Ducharme P, Travers B, Gonzalez-Heydrich J. RAGE Control: Regulate and Gain Emotional Control. Stud Health Technol Inform. 2009; 149:335-43.
  22. Faraone SV, Doyle AE, Lasky-Su J, Sklar PB, D'Angelo E, Gonzalez-Heydrich J, Kratochvil C, Mick E, Klein K, Rezac AJ, Biederman J. Linkage analysis of attention deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet. 2008 Dec 5; 147B(8):1387-91.
  23. MacMillan CM, Withney JE, Korndörfer SR, Tilley CA, Mrakotsky C, Gonzalez-Heydrich JM. Comparative clinical responses to risperidone and divalproex in patients with pediatric bipolar disorder. J Psychiatr Pract. 2008 May; 14(3):160-9.
  24. Baptista-Neto L, Dodds A, Rao S, Whitney J, Torres A, Gonzalez-Heydrich J. An expert opinion on methylphenidate treatment for attention deficit hyperactivity disorder in pediatric patients with epilepsy. Expert Opin Investig Drugs. 2008 Jan; 17(1):77-84.
  25. Torres AR, Whitney J, Gonzalez-Heydrich J. Attention-deficit/hyperactivity disorder in pediatric patients with epilepsy: review of pharmacological treatment. Epilepsy Behav. 2008 Feb; 12(2):217-33.
  26. Macmillan CM, Gonzalez-Heydrich JM. Oxcarbazepine is no more effective than placebo for reducing manic symptoms of bipolar I disorder in children and adolescents. Evid Based Ment Health. 2007 May; 10(2):59.
  27. Zuckerman ML, Vaughan BL, Whitney J, Dodds A, Yakhkind A, MacMillan C, Raches D, Pravdova I, DeMaso DR, Beardslee WR, Gonzalez-Heydrich J. Tolerability of selective serotonin reuptake inhibitors in thirty-nine children under age seven: a retrospective chart review. J Child Adolesc Psychopharmacol. 2007 Apr; 17(2):165-74.
  28. Gonzalez-Heydrich J, Dodds A, Whitney J, MacMillan C, Waber D, Faraone SV, Boyer K, Mrakotsky C, DeMaso D, Bourgeois B, Biederman J. Psychiatric disorders and behavioral characteristics of pediatric patients with both epilepsy and attention-deficit hyperactivity disorder. Epilepsy Behav. 2007 May; 10(3):384-8.
  29. Mrakotsky C, Masek B, Biederman J, Raches D, Hsin O, Forbes P, de Moor C, DeMaso DR, Gonzalez-Heydrich J. Prospective open-label pilot trial of mirtazapine in children and adolescents with social phobia. J Anxiety Disord. 2008; 22(1):88-97.
  30. Gonzalez-Heydrich J, Weiss M, Connolly M, Wambera K, Jan JE, Plioplys S, Dunn DW, Kratochvil CJ. Pharmacological management of a youth with ADHD and a seizure disorder. J Am Acad Child Adolesc Psychiatry. 2006 Dec; 45(12):1527-32.
  31. MacMillan CM, Korndörfer SR, Rao S, Fleisher CA, Mezzacappa E, Gonzalez-Heydrich J. A comparison of divalproex and oxcarbazepine in aggressive youth with bipolar disorder. J Psychiatr Pract. 2006 Jul; 12(4):214-22.
  32. Demaso DR, Marcus NE, Kinnamon C, Gonzalez-Heydrich J. Depression experience journal: a computer-based intervention for families facing childhood depression. J Am Acad Child Adolesc Psychiatry. 2006 Feb; 45(2):158-65.
  33. MacMillan CM, Whitney JE, Korndorfer SR, Mrakotsky C, Tilley CA, Gonzalez-Heydrich J. A Comparison of Divalproex and Risperidone in Pediatric Bipolar Disorder. Presented at the U.S. Psychiatric and Mental Health Congress. 2005.
  34. Whitney J, MacMillan C, Hsin O, Miller T, Johnson F, Gonzalez-Heydrich J. Tolerability of Olanzapine and Ziprasidone in Youths with Bipolar Disorder. Presented at the U.S. Psychiatric and Mental Health Congress. 2005.
  35. Gonzalez-Heydrich J, Whitney J, Hsin O, Mrakotsky C, MacMillan C, Torres A, Pravdova I, DeMaso DR, Bourgeois B, Biederman J. Tolerability of OROS-MPH 18 mg, 36 mg, and 54 mg in Pediatric Epilepsy Plus Attention-Deficit/Hyperactivity Disorder (ADHD). Presented at the American Academy of Child and Adolescent Psychiatry meeting. 2005.
  36. Gonzalez-Heydrich J, Whitney J, Hsin O, Mrakotsky C, MacMillan C, Torres A, Pravdova I, DeMaso DR, Bourgeois B, Biederman J. Tolerability of OROS-MPH 18 mg, 36 mg, and 54 mg in Pediatric Epilepsy Plus Attention-Deficit Hyperactivity Disorder (ADHD). Presented at the Child Neurology Society meeting. 2005.
  37. Gonzalez-Heydrich J, Whitney J, Hsin O, Mrakotsky C, MacMillan C, Torres A, Pravdova I, DeMaso DR, Bourgeois B, Biederman J. Tolerability of OROS-MPH 18 mg, 36 mg, and 54 mg in Pediatric Epilepsy Plus Attention-Deficit/Hyperactivity Disorder (ADHD). Presented at the International League Against Epilepsy meeting. 2005.
  38. Korndorfer SR, MacMillan CM, Fleisher CA, Mezzacappa E, Gonzalez-Heydrich J. A Comparison of Divalproex and Oxcarbazepine in Aggressive Youth with Bipolar Disorder. Presented at the Society for Biological Psychiatry meeting. 2005.
  39. Trivedi H, Wang B, Gonzalez-Heydrich J. Antiepileptic Drugs (AEDs) in the Treatment of Aggression in Children and Adolescents. Child and Adolescent Psychopharmacology News. 2005; 10(1):6-12.
  40. Schonwald A. Gonzalez-Heydrich, J. Psychopharmacology. . Behavioral and Developmental Pediatrics, A Handbook for Primary Care, Editors S Parker, B Zuckerman and M Augustyn. 2005; 83-89.
  41. Hsin O, Miller TP, MacMillan CM, Johnson F, Gonzalez-Heydrich J. Ziprasidone in Pediatric Patients: Efficacy and Tolerability. Presented at the World Psychiatric Association meeting. 2004.
  42. Gonzalez-Heydrich J, Hsin O, Hickory M, Azeem MW, Mrakotsky C, Torres A, Mezzacappa E, DeMaso DR, Bourgeois B, Biederman J. Comparisons of Response to Stimulant Preparations in Pediatric Epilepsy. Presented at the American Academy of Child and Adolescent Psychiatry meeting. 2004.
  43. Gonzalez-Heydrich J, Hsin O, Hickory M, Azeem MW, Mrakrotsky C, Torres A, Mezzacappa E, DeMaso DR, Bourgeois B, Biederman J. Comparisons of Response to Stimulant Preparations in Pediatric Epilepsy. Presented at the American Neurological Association meeting. 2004.
  44. Korndorfer SR, MacMillan CM, Fleisher CA, Mezzacappa E, Beardslee W, Gonzalez-Heydrich J. A Comparison of Divalproex, Gabapentin, and Oxacarbazepine in Aggressive Youth. Presented at the New Clinical Drug Evaluation Unit (NCDEU) meeting. 2004.
  45. MacMillan CM, Miller TP, Hsin O, Johnson F, Gonzalez-Heydrich J. Ziprasidone in Pediatric Patients: Efficacy and Tolerability. Presented at the New Clinical Drug Evaluation Unit (NCDEU). 2004.
  46. Gonzalez-Heydrich J, Pandina GJ, Fleisher CA, Hsin O, Raches D, Bourgeois BF, Biederman J. No seizure exacerbation from risperidone in youth with comorbid epilepsy and psychiatric disorders: a case series. J Child Adolesc Psychopharmacol. 2004; 14(2):295-310.
  47. Gonzalez-Heydrich J, Raches D, Wilens TE, Leichtner A, Mezzacappa E. Retrospective study of hepatic enzyme elevations in children treated with olanzapine, divalproex, and their combination. J Am Acad Child Adolesc Psychiatry. 2003 Oct; 42(10):1227-33.
  48. Gonzalez-Heydrich J. No Seizure Exacerbation from Ziprasidone in Youth with Comorbid Epilepsy and Psychiatric Disorders: A Case Series. Presented at that 16th European College of Neuropsychopharmacology Congress. 2003.
  49. Korndorfer, S.R., MacMillan, C., Fleisher, C., Beardslee, W.R.,& Gonzalez-Heydrich, J. Comparison of Divalproex and Gabapentin: Effectiveness in Aggressive Youth. Presented at the 16th European College of Neuropsychopharmacology Congress. 2003.
  50. Gonzalez-Heydrich J, Raches D, Hsin O, Pravdova I, Hollander SB, Biederman J, Masek B. An Open Trial of the Safety and Efficacy of Mirtazepine in Children and Adolescents with Social Phobia. Presented at the New Clinical Drug Evaluation Unit (NCDEU) meeting. 2003.
  51. Gonzalez-Heydrich J, Raches D, Hsin O, Pravdova I, Hollander SB, Biederman J, Masek B. An Open Trial of the Safety and Efficacy of Mirtazapine in Children and Adolescents with Social Phobia. Presented at the Society for Biological Psychiatry meeting. 2003.
  52. Bers MU, Gonzalez-Heydrich J, Demaso DR. Use of a computer-based application in a pediatric hemodialysis unit: a pilot study. J Am Acad Child Adolesc Psychiatry. 2003 Apr; 42(4):493-6.
  53. DeMaso DR, Gonzalez-Heydrich J, Nyre J, Beardslee WR. Depression Experience Journal: A computer-based intervention for families facing childhood depression. Available online: http://www.experiencejournal.com/depression. 2003.
  54. Gonzalez-Heydrich J. Raches D, Wilens T, Leichtner A, Mezzacappa E. Retrospective study of hepatic enzyme elevations in children treated with olanzapine, divalproex and their combination. Journal of the American Academy of Child & Adolescent Psychiatry. 2003; 42(10):1227-1233.
  55. Azeem M, Gonzalez-Heydrich J, DeMaso DR, Bourgeois BF, and Biederman J. Stimulant Effectiveness in Well Controlled Versus Poorly Controlled Pediatric Epilepsy. Presented at the Institue for Psychiatric Services. 2002.
  56. Gonzalez-Heydrich J, Fleisher CA, Raches D, Bourgeois BF, Pandina GJ, and Biederman J. Risperidone Treatment in Pediatric Patients with Epilepsy: Systematic Review of Medical Records. Presented at the International Conference on Child & Adolescent Mental Health. 2002.
  57. Fleisher CA, Gonzalez-Heydrich J, Korndorfer SR, Raches D, and Mezzacappa E. Aggressive Youth on Divalproex: Effectiveness as Reviewed in Medical Records. Presented at the Meeting of the American Psychiatric Association. 2002.
  58. Gonzalez-Heydrich J, Fleisher CA, Raches D, Bourgeois BF, Pandina GJ, and Biederman J. Risperidone Treatment in Pediatric Patients with Epilepsy: Systematic Review of Medical Records. Presented at the Society for Biological Psychiatry. 2002.
  59. Azeem M, Gonzalez-Heydrich J, DeMaso DR, Bourgeois BF, and Biederman J. Stimulant Effectiveness in Well Controlled Versus Poorly Controlled Pediatric Epilepsy. Presented at the Annual Boston Society of Neurology and Psychiatry Cobb Assembly. 2002.
  60. Azeem M, Gonzalez-Heydrich J, DeMaso DR, Bourgeois BF, Biederman J. Stimulant Effectiveness in Well Controlled Versus Poorly Controlled Pediatric Epilepsy. Presented at the Harvard Consolidated Department of Psychiatry Research Day. 2002.
  61. Bers MU, Gonzalez-Heydrich J, DeMaso DR. Future of technology to augment patient support in hospitals. Stud Health Technol Inform. 2002; 80:231-44.
  62. Cesena M, Gonzalez-Heydrich J, Szigethy E, Kohlenberg TM, DeMaso DR. A case series of eight aggressive young children treated with risperidone. J Child Adolesc Psychopharmacol. 2002; 12(4):337-45.
  63. Fleisher, C.A., Gonzalez-Heydrich, J., Korndorfer, S.R., Raches, D., Mezzacappa, E. Aggressive Youth on Divalproex: Effectiveness as Reviewed in Medical Records. Journal of Adolescent Health. 2002; 30(2):125.
  64. Raches D, Pravdova I, DeMaso DR, Beardslee W, and Gonzalez-Heydrich J. Sertaline Treatment for Young Children: Systematic Review of Medical Records. Journal of Child and Adolescent Psychopharmacology. 2002; 12(4):294-5.
  65. Gonzalez-Heydrich J, Steingard RJ, Putnam FW, De Bellis MD, Beardslee W, Kohane IS. Corticotropin releasing hormone increases apparent potency of adrenocorticotropic hormone stimulation of cortisol secretion. Med Hypotheses. 2001 Nov; 57(5):544-8.
  66. Gonzalez-Heydrich J, Fleisher CA, Raches D, Bourgeois BF, Pandina GJ, Biederman J, and Janssen P. Risperidone Treatment in Pediatric Patients with Epilepsy: Systematic Review of Medical Records. Presented at the Meeting of the American College of Neuropsychopharmacology. 2001.
  67. Wilens TE, Prince JB, Biederman J, Spencer T, Doyle R, Gonzalez-Heydrich J, Hammerness PG, Waxmonsky J, Monuteaux BA, Goldman S, Brown S, and Van Patten SL. An Open Study of Sustained Release Bupropion in Adults with ADHD and Substance Use Disorders. Presented at the Meeting of the American Academy of Child and Adolescent Psychiatry. 2001.
  68. Gonzalez-Heydrich J, Irwin C, Raches D, Beardslee W, and DeMaso DR. 3 Years of a Pediatric Psychopharmacology Electronic Medical Records System. Presented at the Meeting of the American Academy of Child and Adolescent Psychiatry. 2001.
  69. Van Horn M, DeMaso DR, Gonzalez-Heydrich J, Erickson JD. Illness-related concerns of mothers of children with congenital heart disease. J Am Acad Child Adolesc Psychiatry. 2001 Jul; 40(7):847-54.
  70. Gonzalez-Heydrich J, Wilens TE, and Beardslee W. Nefazodone for Depression in Bipolar and Non-Bipolar Youth: Systematic Review of Electronic Medical Records. Presented at the New Clinical Drug Evaluation Unit (NCDEU) meeting. 2001.
  71. Cesena M, Gonzalez-Heydrich J, Kohlenberg TM, Szigethy E, and DeMaso DR. Risperidone Treatment for Aggressive Preschool Children: Systematic Review of Medical Records. Presented at the New Clinical Drug Evaluation Unit (NCDEU) meeting. 2001.
  72. Ackermann E, Bromley D, DeMaso DR, Gibson SFF, Gonzalez-Heydrich J, Karlin JG, Marks J, Shen Chia, Strohecker C, inventors; Mitsubishi Electric Research Laboratories Inc. Method and system for displaying icons representing informational items stored in a database. 2001.
  73. Ackerman E, Bromley D, DeMaso DR, Gibson SFF, Gonzalez-Heydrich J, Karlin JG, Marks J, Shen Chia, Strohecker C, inventors; Mitsubishi Denki Kabushiki Kaisha, et. al. Method and system for displaying icons representing informational items stored in a database. 2001.
  74. Bers MU, Gonzalez-Heydrich J, Raches D, DeMaso DR. Zora: a pilot virtual community in the pediatric dialysis unit. Stud Health Technol Inform. 2001; 84(Pt 1):800-4.
  75. Frazier JA, Biederman J, Tohen M, Feldman PD, Jacobs TG, Toma V, Rater MA, Tarazi RA, Kim GS, Garfield SB, Sohma M, Gonzalez-Heydrich J, Risser RC, Nowlin ZM. A prospective open-label treatment trial of olanzapine monotherapy in children and adolescents with bipolar disorder. J Child Adolesc Psychopharmacol. 2001; 11(3):239-50.
  76. DeMaso DR, Gonzalez-Heydrich J. Cardiac Experience Journal: A computer-based intervention for families facing pediatric heart disease. Available online: http://www.experiencejournal.com. 2001.
  77. Umaschi Bers M, Gonzalez-Heydrich J, Raches D, and DeMaso DR. Zora: A Pilot Virtual Community in the Pediatric Dialysis Unit. MEDINFO 2001. Proceedings of the 12th World Congress on Medical Informatics. 2001; 10:800-804.
  78. Gonzalez-Heydrich J, Steingard RJ, Putnam F, DeBellis MD, Beardslee W, Kohane IS. Corticotropin releasing hormone increases Apparent Potency of ACTH Stimulation of Cortisol Secretion. Medical Hypothesis. 2001; 57(5):544-548.
  79. Gonzalez-Heydrich J, DeMaso DR, Irwin C, Steingard RJ, Kohane IS, Beardslee WR. Implementation of an electronic medical record system in a pediatric psychopharmacology program. Int J Med Inform. 2000 Jul; 57(2-3):109-16.
  80. DeMaso DR, Gonzalez-Heydrich J, Erickson JD, Grimes VP, Strohecker C. The experience journal: a computer-based intervention for families facing congenital heart disease. J Am Acad Child Adolesc Psychiatry. 2000 Jun; 39(6):727-34.
  81. Frazier J, Biederman J, Jacobs TG, Tohen M, Toma V, Feldman PD, Rater MA, Tarazi RA, Kim GA, Garfield SB, Gonzalez-Heydrich J, and Zachary MN. . Olanzapine in the Treatment of Bipolar Disorder in Juveniles. Presented at the New Clinical Drug Evaluation Unit (NCDEU) meeting. 2000.
  82. Wilens T, Prince J, Spencer T, Doyle R, Goldman S, Girard K, Monutaeux M, Gonzalez J, Murphy K, Frazier J, and Biederman J. Bupropion SR for Attention Deficit Hyperactivity Disorder (ADHD)in Adults with Bipolar Disorder (BPD)and ADHD. Presented at the New Clincal Drug Evaluation Unit (NCDEU) meeting. 2000.
  83. Bers M, Gonzalez-Heydrich J, DeMaso DR, Corsini E, and Harmon W. . Zora: A Pilot Virtual Community in the Pediatric Dialysis Unit. Presented at the Pediatric Academic Societies and American Academy of Pediatrics Joint Meeting. 2000.
  84. Thiele EA, Gonzalez-Heydrich J, Riviello JJ. Epilepsy in children and adolescents. Child Adolesc Psychiatr Clin N Am. 1999 Oct; 8(4):671-94.
  85. Gonzalez-Heydrich J, Steingard RJ, Putnam F, Beardslee W, Kohane IS. Using 'off the shelf', computer programs to mine additional insights from published data: diurnal variation in potency of ACTH stimulation of cortisol secretion revealed. Comput Methods Programs Biomed. 1999 Mar; 58(3):227-38.
  86. Umaschi Bers M, Ackermann E, Cassell J, Donegan B, Gonzalez-Heydrich J, DeMaso DR, Strohecker C, Lualdi S, Bromley D, and Karlin J. Interactive Storytelling Environments: Coping with Cardiac Illness at Boston's Children's Hospital. Proceedings of CHI'98, Association of Computing CHI'98 Machinery Special Interest Group in Computer-Human Interaction Conference. 1998; 603-609.
  87. Gonzalez-Heydrich J, Bromley D, Strohecker C, Marks J, DeMaso DR, Ackermann E, Gibson S, Shen C, Umaschi M. Experience journals: using computers to share personal stories about illness and medical intervention. Stud Health Technol Inform. 1998; 52 Pt 2:1325-9.
  88. Gonzalez-Heydrich J, Bromley D, Strohecker C, Marks J, DeMaso DR, Ackermann E, Gibson S, Shen C, and Umaschi M. Experience Journals: Using Computers to Share Stories About Illness and Medical Intervention. MEDINFO 98. Proceedings of the 9th World Congress on Medical Informatics. 1998; 1323-1327.
  89. Gonzalez-Heydrich J, Bromley D, Strohecker C, Marks J, DeMaso DR, Ackermann E, Gibson S, Shen C, and Umaschi M. Experience Journals: Using Computers to Share Stories About Illness and Medical Intervention. MEDINFO 98. Proceedings of the 9th World Congress on Medical Informatics. 1998; 1323-1327.
  90. Gonzalez-Heydrich J, Steingard RJ, Putnam FW, De Bellis M, Beardslee W, and Kohane IS. Computer Modeling of Human Data Reveals CRH Increases the Potency of ACTH Effect on Cortisol and Rate of Cortisol Degradation With Differences in Sexually Abused Girls. Presented at the Harvard Consolidated Department of Psychiatry Research Day. 1997.
  91. Gonzalez-Heydrich J, Steingard RJ, Putnam FW, De Bellis M, Beardslee W, and Kohane IS. Computer Modeling of Human Data Reveals CRH Increases the Potency of ACTH Effect on Cortisol and Rate of Cortisol Degradation With Differences in Sexually Abused Girls. Presented at the Dynamical Neurosciences Symposium at the Society of Neurosciences Meeting. 1996.
  92. Gonzalez-Heydrich J. A Neural Network Approach to Modelling Personality Development. Presented at the Dynamical Neurosciences Symposium at the Society of Neurosciences Meeting. 1996.
  93. Gonzalez-Heydrich J. Book Review of Child and Adolescent Depression: Clinical and Research Perspectives. New England Journal of Medicine. 1996.
  94. Gonzalez-Heydrich J, Steingard RJ, Van Maasdam J, Shorrock KL, Gold J, Zurakowski D, Laub D. Transexuals: MCMI-II Severe Personality Disorder Incidence Depends on Setting and Sex. Presented at the Harvard Consolidated Department of Psychiatry Research Day. 1995.
  95. Gonzalez-Heydrich J, Steingard RJ, and Kohane I . A Computer Simulation of the Hypothalamic-Pituitary-Adrenal Axis. Presented at the American College of Neuropsychopharmacology Meeting. 1994.
  96. Gonzalez-Heydrich J, Steingard RJ, Kohane I. A Computer Stimulation of the Hypothalamic-Pituitary-Adrenal Axis. Proceedings of the Annual Symposium on Computer Applications in Medical Care. 1994; 1010.
  97. Gonzalez-Heydrich J. Book Review of The Kaspar Hauser Syndrome of "Psychosocial Dwarfism": Deficient Statural, Intellectual and Social Growth Induced by Child Abuse. New England Journal of Medicine. 1994; 331(15):1031.
  98. Gonzalez-Heydrich J, Steingard RJ, Kohane I. A computer simulation of the hypothalamic-pituitary-adrenal axis. Proc Annu Symp Comput Appl Med Care. 1994; 1010.
  99. Gonzalez-Heydrich J, Van Maasdam J, Gold J, and Laub DR. Rates of Personality Disorders in Gender Dysphorics Using a Self Report Inventory, the MCMI-II. Presented at the XIII International Sympsium on Gender Dysphoria. 1993.
  100. Gonzalez-Heydrich J. Using neural networks to model personality development. Med Hypotheses. 1993 Aug; 41(2):123-30.
  101. Gonzalez-Heydrich J, Kerner JA, Steiner H. Testing the psychogenic vomiting diagnosis. Four pediatric patients. Am J Dis Child. 1991 Aug; 145(8):913-6.
  102. Gonzalez-Heydrich J, Kerner JA, and Steiner H. Testing the Psychogenic Vomitting Diagnosis: Four Pediatric Patients. American Journal of Diseases of Children. 1991; 148(8):913-916.
  103. Gonzalez-Heydrich J, Peroutka SJ. Postsynaptic localization of 5-HT1D receptor binding sites in human caudate. Exp Neurol. 1991 Jul; 113(1):28-30.
  104. Gonzalez-Heydrich J, Peroutka SJ. Serotonin receptor and reuptake sites: pharmacologic significance. J Clin Psychiatry. 1990 Apr; 51 Suppl:5-12; discussion 13.
  105. Money J, Leal J, and Gonzalez-Heydrich J. Aphrodiesiology: History, Folklore and Efficacy. In: The Pharmacology and Endocrinology of Sexual Function. Handbook of Sexology; series editors, Money, J., and Musaph, H. 1988; 6:499-515.
  106. Gonzalez J, Whitehouse PJ, Yagaloff, KA, Hartig PR, Markus K, Kuhar MJ, Proce DL, Steele CS, Folstein MF, and Powell SK. . Reductions of Serotonergic Receptors in Alzheimer's Disease: An Autoradiographic Study. Abstract presented at the Meeting of the American Academy of Neurology, 1986. 1986.
To schedule an appointment: Call 617-355-6680 or Request an Appointment

Locations

We are grateful to have been ranked #1 on U.S. News & World Report's list of the best children's hospitals in the nation for the third year in a row, an honor we could not have achieved without the patients and families who inspire us to do our very best for them. Thanks to you, Boston Children's is a place where we can write the greatest children's stories ever told.”
- Sandra L. Fenwick, President and CEO

Boston Children's Hospital 300 Longwood Avenue, Boston, MA 02115 617-355-6000 | 800-355-7944

Close